Clinical trial
Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis
NCT05902455 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Differential Mobility Spectrometry (DMS) Based Oral Tumor Analysis
- Lead sponsor
- Tampere University Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 25, 2021
- Completion date
- June 30, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
oral squamous cell carcinoma